Highbridge Capital Management’s Repligen RGEN Stock Holding History

Highbridge Capital Management’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-14,300	Closed	-$548K	–	1907
2017 Q3	$548K	Buy	+14,300	New	+$599K	0.01%	872
2016 Q2	–	Sell	-11,200	Closed	-$300K	–	1692
2016 Q1	$300K	Buy	+11,200	New	+$274K	0.01%	1181
2015 Q1	–	Sell	-54,900	Closed	-$1.09M	–	1553
2014 Q4	$1.09M	Sell	54,900 -99,300	-64%	-$2.22M	0.01%	624
2014 Q3	$3.07M	Buy	154,200 +143,400	+1,328%	+$3.02M	0.04%	381
2014 Q2	$246K	Sell	10,800 -14,400	-57%	-$256K	﹤0.01%	923
2014 Q1	$324K	Buy	+25,200	New	+$361K	﹤0.01%	819

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Highbridge Capital Management's RGEN Position: Q4 2017 in Review

Highbridge Capital Management sold out of Repligen (RGEN) in Q4 2017, closing a stake of 13,845 shares — an estimated $531K sold.

Highbridge Capital Management first reported a position in RGEN in Q3 2016 and held it in 2 quarters. The position peaked at $531K in Q3 2017. 184 funds tracked by Wall St. Rank hold RGEN as of Q4 2017.

Highbridge Capital Management reported no remaining Repligen position as of Q4 2017 after selling out during the quarter.
Highbridge Capital Management sold 13,845 Repligen shares in Q4 2017, an estimated $531K.
Highbridge Capital Management first reported a position in Repligen in Q3 2016 and held it in 2 quarters.
Highbridge Capital Management's Repligen position peaked at $531K in Q3 2017.
184 funds tracked by Wall St. Rank held Repligen as of Q4 2017.

Based on Highbridge Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.